Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

4.860
+0.0901.89%
Volume:67.70M
Turnover:327.34M
Market Cap:56.10B
PE:9.16
High:4.870
Open:4.820
Low:4.790
Close:4.770
Loading ...

CSPC Pharmaceutical Gets China Nod for Tumor Drug Clinical Trial

MT Newswires Live
·
2 hours ago

BRIEF-CSPC Pharmaceutical Says JMT108 Obtains Clinical Trial Approval In China

Reuters
·
Yesterday

CSPC Pharmaceutical - Approval From National Medical Products Administration of China

THOMSON REUTERS
·
Yesterday

CSPC Pharmaceutical - Jmt108 (Bi-Functional Fusion Protein Drug) Obtains Clinical Trial Approval in China

THOMSON REUTERS
·
Yesterday

CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Anti-Tumor Indication of Sirolimus in China

MT Newswires Live
·
04 Mar

CSPC Pharmaceutical - Sirolimus for Injection (Albumin-Bound) Was Granted Breakthrough Therapy Designation in China

THOMSON REUTERS
·
28 Feb

Greater China Stocks Rise; Hong Kong Sees Largest Increase

Dow Jones
·
26 Feb

Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$6.48 From HK$7.02, Keeps at Buy

MT Newswires Live
·
26 Feb

CSPC Pharmaceutical's 2024 Profit to Fall 26%; Shares Slide 4%

MT Newswires Live
·
26 Feb

BRIEF-CSPC Pharmaceutical Expects Decrease In Profit Attributable For Year Of 26%

Reuters
·
25 Feb

CSPC Pharmaceutical Sees Decrease in Profit Attributable for Year of 26%

THOMSON REUTERS
·
25 Feb

CSPC Pharmaceutical - Expected Result Due to Decrease in Revenue of Finished Drugs Business for Year

THOMSON REUTERS
·
25 Feb

Radiance Biopharma Enters Exclusive License for Ror-1 Targeted Antibody Drug Conjugate

THOMSON REUTERS
·
20 Feb

CSPC Pharmaceutical Group's Subsidiary Signs Exclusive Licensing Agreement for Cancer Drug

MT Newswires Live
·
19 Feb

BRIEF-CSPC Pharmaceutical Receives Exclusive License Agreement For SYS6005 With Radiance Biopharma

Reuters
·
19 Feb

CSPC Pharmaceutical - Exclusive License Agreement for Sys6005 With Radiance Biopharma

THOMSON REUTERS
·
19 Feb